Prostate stem cells and cancer

Alexander Yu Nikitin, Andres Matoso, P. Roy-Burman

Research output: Contribution to journalReview article

Abstract

Properties shared by neoplastic and stem cells indicate a possibility that somatic stem cells or transit-amplifying cells that have reacquired stem cell properties, particularly the ability for self-renewal, represent favorable targets for malignant transformation. In this review we discuss significance of the stem cell model for understanding prostate cancer pathogenesis and describe relevant studies in animals. It is proposed that dissemination of rare cancer stem cells may lead to metastatic disease and that resistance of such cells to multiple drugs and androgen ablation make them responsible for failure of current treatments. Thus further understanding of the cancer stem cell biology is needed for development of efficient rationally designed therapy permitting better targeting and better treatment outcomes for patients with prostate neoplasms.

Original languageEnglish (US)
Pages (from-to)1043-1049
Number of pages7
JournalHistology and Histopathology
Volume22
Issue number7-9
StatePublished - Jul 1 2007
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Prostate
Prostatic Neoplasms
Stem Cells
Adult Stem Cells
Disease Resistance
Treatment Failure
Androgens
Cell Biology
Pharmaceutical Preparations
Therapeutics

Keywords

  • Adult stem cells
  • Androgen ablation
  • Carcinogenesis
  • Mouse models
  • Neuroendocrine differentiation
  • Prostate

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Histology
  • Cell Biology

Cite this

Nikitin, A. Y., Matoso, A., & Roy-Burman, P. (2007). Prostate stem cells and cancer. Histology and Histopathology, 22(7-9), 1043-1049.

Prostate stem cells and cancer. / Nikitin, Alexander Yu; Matoso, Andres; Roy-Burman, P.

In: Histology and Histopathology, Vol. 22, No. 7-9, 01.07.2007, p. 1043-1049.

Research output: Contribution to journalReview article

Nikitin, AY, Matoso, A & Roy-Burman, P 2007, 'Prostate stem cells and cancer', Histology and Histopathology, vol. 22, no. 7-9, pp. 1043-1049.
Nikitin AY, Matoso A, Roy-Burman P. Prostate stem cells and cancer. Histology and Histopathology. 2007 Jul 1;22(7-9):1043-1049.
Nikitin, Alexander Yu ; Matoso, Andres ; Roy-Burman, P. / Prostate stem cells and cancer. In: Histology and Histopathology. 2007 ; Vol. 22, No. 7-9. pp. 1043-1049.
@article{e560c4443aa84b92831edd194fc17d7c,
title = "Prostate stem cells and cancer",
abstract = "Properties shared by neoplastic and stem cells indicate a possibility that somatic stem cells or transit-amplifying cells that have reacquired stem cell properties, particularly the ability for self-renewal, represent favorable targets for malignant transformation. In this review we discuss significance of the stem cell model for understanding prostate cancer pathogenesis and describe relevant studies in animals. It is proposed that dissemination of rare cancer stem cells may lead to metastatic disease and that resistance of such cells to multiple drugs and androgen ablation make them responsible for failure of current treatments. Thus further understanding of the cancer stem cell biology is needed for development of efficient rationally designed therapy permitting better targeting and better treatment outcomes for patients with prostate neoplasms.",
keywords = "Adult stem cells, Androgen ablation, Carcinogenesis, Mouse models, Neuroendocrine differentiation, Prostate",
author = "Nikitin, {Alexander Yu} and Andres Matoso and P. Roy-Burman",
year = "2007",
month = "7",
day = "1",
language = "English (US)",
volume = "22",
pages = "1043--1049",
journal = "Histology and Histopathology",
issn = "0213-3911",
publisher = "Histology and Histopathology",
number = "7-9",

}

TY - JOUR

T1 - Prostate stem cells and cancer

AU - Nikitin, Alexander Yu

AU - Matoso, Andres

AU - Roy-Burman, P.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Properties shared by neoplastic and stem cells indicate a possibility that somatic stem cells or transit-amplifying cells that have reacquired stem cell properties, particularly the ability for self-renewal, represent favorable targets for malignant transformation. In this review we discuss significance of the stem cell model for understanding prostate cancer pathogenesis and describe relevant studies in animals. It is proposed that dissemination of rare cancer stem cells may lead to metastatic disease and that resistance of such cells to multiple drugs and androgen ablation make them responsible for failure of current treatments. Thus further understanding of the cancer stem cell biology is needed for development of efficient rationally designed therapy permitting better targeting and better treatment outcomes for patients with prostate neoplasms.

AB - Properties shared by neoplastic and stem cells indicate a possibility that somatic stem cells or transit-amplifying cells that have reacquired stem cell properties, particularly the ability for self-renewal, represent favorable targets for malignant transformation. In this review we discuss significance of the stem cell model for understanding prostate cancer pathogenesis and describe relevant studies in animals. It is proposed that dissemination of rare cancer stem cells may lead to metastatic disease and that resistance of such cells to multiple drugs and androgen ablation make them responsible for failure of current treatments. Thus further understanding of the cancer stem cell biology is needed for development of efficient rationally designed therapy permitting better targeting and better treatment outcomes for patients with prostate neoplasms.

KW - Adult stem cells

KW - Androgen ablation

KW - Carcinogenesis

KW - Mouse models

KW - Neuroendocrine differentiation

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=34447130176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447130176&partnerID=8YFLogxK

M3 - Review article

C2 - 17523082

AN - SCOPUS:34447130176

VL - 22

SP - 1043

EP - 1049

JO - Histology and Histopathology

JF - Histology and Histopathology

SN - 0213-3911

IS - 7-9

ER -